Research Article
Prevalence and Possible Risk Factors of Low Bone Mineral Density in Untreated Female Patients with Systemic Lupus Erythematosus
Table 3
Characteristics of SLE patients with normal and low BMD at lumbar spine and total hip.
| Variable | Normal BMD | Low BMD | |
| Demographic variables | | | | Age# | 31.6 ± 8.9 | 33.9 ± 16.1 | 0.869 | BMI# | 20.7 ± 3.5 | 20.3 ± 2.8 | 0.730 | Clinical variables | | | | Disease duration# | 24.1 ± 34.7 | 20.1 ± 34.5 | 0.895 | Serum creatinine# | 54.6 ± 26.7 | 55.2 ± 20.3 | 0.651 | Serum albumin# | 31.7 ± 5.8 | 32.3 ± 8.6 | 0.216 | 24-hour urine protein# | 0.56 ± 0.75 | 0.62 ± 1.02 | 0.586 | Serum TC# | 3.3 ± 0.9 | 4.2 ± 1.8 | 0.007 | Serum triglyceride# | 2.0 ± 1.1 | 2.0 ± 1.7 | 0.332 | Serum LDL-c# | 1.9 ± 0.6 | 2.4 ± 1.2 | 0.055 | ESR# | 56.1 ± 34.7 | 54.9 ± 33.0 | 0.948 | CRP# | 10.8 ± 12.9 | 10.8 ± 12.7 | 0.963 | Complement 3# | 0.57 ± 0.32 | 0.59 ± 0.33 | 0.892 | Complement 4# | 0.10 ± 0.09 | 0.10 ± 0.09 | 0.909 | SLEDAI# | 11.7 ± 6.0 | 10.8 ± 5.2 | 0.579 | Bone metabolism variables | | | | Serum 25-[OH]D# | 12.2 ± 7.8 | 11.8 ± 6.7 | 0.995 | Serum calcium | 2.0 ± 0.2 | 2.0 ± 0.2 | 0.978 | Serum phosphate | 1.2 ± 0.3 | 1.0 ± 0.3 | 0.715 | PTH# | 34.8 ± 23.7 | 38.1 ± 21.3 | 0.342 | OC# | 10.1 ± 5.5 | 11.2 ± 7.9 | 0.880 | CTX# | 500.8 ± 357.8 | 633.7 ± 498.0 | 0.373 |
|
|
The Student -test; Mann-Whitney test. BMD = bone mineral density; BMI = body mass index; TC = total cholesterol; LDL-c = low density lipoprotein cholesterol; ESR = erythrocyte sedimentation rate; CRP = C-reactive protein; SLEDAI = Systemic Lupus Erythematosus Disease Activity Index; 25-[OH]D = 25-hydroxyvitamin D; PTH = parathyroid hormone; OC = osteocalcin; CTX = C-terminal cross-linking telopeptide of type I collagen.
|